SOLICITATION NOTICE
65 -- Hologic Supplies
- Notice Date
- 9/26/2023 6:39:38 AM
- Notice Type
- Presolicitation
- NAICS
- 325413
— In-Vitro Diagnostic Substance Manufacturing
- Contracting Office
- DEFENSE HEALTH AGENCY FALLS CHURCH VA 22042 USA
- ZIP Code
- 22042
- Solicitation Number
- 0011958622
- Response Due
- 10/11/2023 7:00:00 AM
- Archive Date
- 12/31/2023
- Point of Contact
- Derek Bell
- E-Mail Address
-
derek.j.bell.civ@health.mil
(derek.j.bell.civ@health.mil)
- Description
- The Defense Health Agency (DHA) Southeast Contracting Division intends to negotiate a contract on a sole source basis (IAW FAR 13.501(a) sole source acquisitions). The proposed source is Hologic Sales and Service, LLC (Hologic) of 250 Campus Drive, Marlborough, MA 01752. The requirement is Brand Name Only (BNO) to the Hologic Panther. �The requirement is for the following procedures: �Hologic Aptima SARS-CoV-2 Assay, 250-test (PRD-06419), Hologic 123Aptima SARS-CoV-2 Assay Controls (PRD-06420), which are required for COVID-19 real-time testing on the existing Hologic Panther analyzer; Hologic M GEN Aptima, 100-T, AS, (PRD-03919), is required for testing for Mycoplasma genitalium testing on the Hologic Panther analyzer; Hologic BV Assay, Aptima, 100T, IVD (PRD-05186), is required for testing for Bacterial Vaginosis on the Hologic Panther analyzer; �and Hologic CV/TV Assay, Aptima, 100T, IVD (PRD-05189), is required for testing for Candida vaginitis and trichomoniasis on the Hologic Panther analyzer. The following quantities are required: Item Number�� �Product�� �Quantity PRD-06419�� �Aptima SARS-CoV-2 Assay EUA, 250-test�� �123 PRD-06420�� �Aptima SARS-CoV-2 Assay Controls�� �62 PRD-03919�� �M GEN Aptima, 100-T, AS�� �57 PRD-05186�� �BV Assay, Aptima, 100T, IVD�� �55 PRD-05189�� �CV/TV Assay, Aptima, 100T�� �55 Anticipated delivery dates starting in November. �Four (4) option periods are anticipated.� There are not set-aside restrictions for this requirement. �The intended procurement will be classified under North America Industry Classification System (NAICS) 325413-In-Vitro Diagnostic Substance Manufacturing. �This notice of intent is not a request for competitive proposals and no solicitation document exists for this requirement. �However, parties interested in responding to this notice will need to submit technical data sufficient to determine capability in providing the same product. �All capability statements received by the closing date of this synopsis will be considered by the Government. �A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government. �Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. If a vendor challenges the basis of this requirement, please email product capability statements (formats for submission: PDF, MS Word, or MS Excel) to Derek Bell at derek.j.bell.civ@health.mil. �Closing date for challenges is no later than 10:00 AM ET on 11 October 2023. �No phone calls will be accepted. �
- Web Link
-
SAM.gov Permalink
(https://sam.gov/opp/342265f95edf4c979eb7df2c4ec0f021/view)
- Record
- SN06845732-F 20230928/230926230102 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |